John A. DeFord's most recent trade in Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A was a trade of 89,139 Class A Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on June 16, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Maravai LifeSciences Holdi... | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 2.16 per share. | 16 Jun 2025 | 89,139 | 159,185 | - | 2.2 | 192,540 | Class A Common Stock |
Globus Medical Inc - Ordin... | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
Maravai LifeSciences Holdi... | John A. DeFord | Director | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 12 Nov 2024 | 17,500 | 70,046 | - | 5.8 | 100,625 | Class A Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 249.03 per share. | 01 Nov 2024 | 747 | 4,694 (0%) | 0% | 249.0 | 186,025 | NDSN |
Maravai LifeSciences Holdi... | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 10.78 per share. | 23 May 2024 | 20,645 | 52,546 | - | 10.8 | 222,553 | Class A Common Stock |
Globus Medical Inc - Ordin... | DeFord A. John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
Globus Medical Inc - Ordin... | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 15,578 | 15,578 (0%) | 0% | - | Class A Common Stock | |
Globus Medical Inc - Ordin... | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 251.61 per share. | 31 Jul 2023 | 89 | 3,034 (0%) | 0% | 251.6 | 22,393 | NDSN |
Maravai LifeSciences Holdi... | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 31,901 | 31,901 | - | 0 | Class A Common Stock | |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 216.31 per share. | 28 Apr 2023 | 104 | 2,937 (0%) | 0% | 216.3 | 22,496 | NDSN |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 243.30 per share. | 31 Jan 2023 | 92 | 2,818 (0%) | 0% | 243.3 | 22,384 | NDSN |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 225.93 per share. | 31 Oct 2022 | 730 | 2,726 (0%) | 0% | 225.9 | 164,929 | NDSN |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 225.00 per share. | 31 Oct 2022 | 100 | 1,996 (0%) | 0% | 225 | 22,500 | NDSN |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 230.99 per share. | 29 Jul 2022 | 97 | 1,891 (0%) | 0% | 231.0 | 22,406 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 215.69 per share. | 29 Apr 2022 | 104 | 1,790 (0%) | 0% | 215.7 | 22,432 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 232.54 per share. | 31 Jan 2022 | 96 | 1,678 (0%) | 0% | 232.5 | 22,324 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 238.43 per share. | 29 Oct 2021 | 608 | 1,582 (0%) | 0% | 238.4 | 144,965 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 254.22 per share. | 29 Oct 2021 | 79 | 974 (0%) | 0% | 254.2 | 20,083 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 226.12 per share. | 30 Jul 2021 | 88 | 892 (0%) | 0% | 226.1 | 19,899 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 211.41 per share. | 30 Apr 2021 | 94 | 804 (0%) | 0% | 211.4 | 19,873 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 178.99 per share. | 29 Jan 2021 | 85 | 707 (0%) | 0% | 179.0 | 15,214 | Common Stock |
Nordson | John A. DeFord | Director | Grant, award, or other acquisition of securities at price $ 196.27 per share. | 23 Nov 2020 | 622 | 622 (0%) | 0% | 196.3 | 122,080 | Common Stock |